IP due diligence: key areas of analysis in biotech and pharma transactions

Financier Worldwide
September 2011

The article discuses the importance of investigating federal funding and collaborative agreements with the government during IP due diligence of a pharmaceutical or biotech company.

View Attachment (PDF)